Fluorine in PDB 5ryz: EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z2856434868

The structure of EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z2856434868, PDB code: 5ryz was solved by W.J.Bradshaw, V.L.Katis, J.A.Newman, F.Von Delft, C.H.Arrowsmith, A.M.Edwards, C.Bountra, O.Gileadi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	61.17 / 1.61
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	38.530, 77.550, 99.520, 90.00, 90.00, 90.00
R / Rfree (%)	21.1 / 24.4

The binding sites of Fluorine atom in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z2856434868 (pdb code 5ryz). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z2856434868, PDB code: 5ryz:

Fluorine binding site 1 out of 1 in the EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z2856434868


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of EPB41L3 Pandda Analysis Group Deposition -- Crystal Structure of the Ferm Domain of Human EPB41L3 in Complex with Z2856434868 within 5.0Å range: probe atom residue distance (Å) B Occ A:F401 b:23.7 occ:0.52 F1 A:NVY401 0.0 23.7 0.5 C13 A:NVY401 1.3 23.8 0.5 C12 A:NVY401 2.3 23.5 0.5 C8 A:NVY401 2.4 24.0 0.5 N2 A:NVY401 2.8 25.4 0.5 C A:GLY319 3.2 20.1 1.0 CG A:LEU321 3.2 26.4 1.0 CD1 A:LEU321 3.2 30.2 1.0 N A:GLY319 3.4 24.1 1.0 O A:GLY319 3.4 20.8 1.0 SG A:CYS316 3.4 25.4 1.0 CA A:GLY319 3.5 23.2 1.0 N A:LEU320 3.5 23.0 1.0 C11 A:NVY401 3.6 23.0 0.5 C9 A:NVY401 3.6 23.8 0.5 O A:LEU320 3.8 27.8 1.0 C A:LEU320 3.8 26.7 1.0 CD2 A:LEU321 4.0 31.9 1.0 C A:SER318 4.1 25.4 0.5 C10 A:NVY401 4.1 22.5 0.5 N A:LEU321 4.1 23.5 1.0 CB A:SER318 4.2 24.4 0.5 CA A:LEU320 4.2 23.8 1.0 C5 A:NVY401 4.2 25.1 0.5 CB A:LEU321 4.4 25.1 1.0 CA A:LEU321 4.6 26.0 1.0 CB A:ARG331 4.6 31.6 0.5 CA A:SER318 4.6 25.1 0.5 O A:PHE332 4.7 31.1 1.0 CG A:ARG331 4.7 32.2 0.5 C6 A:NVY401 4.8 25.0 0.5 O A:SER318 4.8 26.6 0.5 N A:PHE332 4.9 33.3 1.0 CA A:ARG331 4.9 32.1 0.5 C4 A:NVY401 5.0 25.4 0.5

W.J.Bradshaw, V.L.Katis, J.A.Newman, F.Von Delft, C.H.Arrowsmith, A.M.Edwards, C.Bountra, O.Gileadi. EPB41L3 Pandda Analysis Group Deposition To Be Published.